THARIMMUNE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.331 USD | +1.53% |
|
-10.70% | -35.38% |
| May. 22 | Tharimmune to Implement 1-for-15 Reverse Stock Split | MT |
| May. 09 | Tharimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 1.285 | 3.842 | - |
| Enterprise Value (EV) 1 | 1.285 | 3.842 | 3.842 |
| P/E ratio | -0.07 x | - | - |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | - | - | - |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 2,525 | 11,786 | - |
| Reference price 2 | 0.5090 | 0.3260 | 0.3260 |
| Announcement Date | 2/23/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | - |
| EBITDA | - | - | - | - |
| EBIT 1 | - | - | -12 | -14.5 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | -2.207 | -9.319 | - | - |
| Net margin | - | - | - | - |
| EPS | -8.750 | -7.140 | - | - |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 4/1/22 | 2/23/24 | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 4/1/22 | 2/23/24 | - | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.326
USD
Average target price
5
USD
Spread / Average Target
+1,433.74%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -35.38% | 3.84M | |
| +10.50% | 115B | |
| +12.15% | 106B | |
| -4.37% | 24.69B | |
| -2.33% | 21.97B | |
| -6.03% | 19.27B | |
| -13.28% | 17.56B | |
| -40.50% | 17.32B | |
| +6.05% | 14.03B | |
| +30.93% | 12.13B |
- Stock Market
- Equities
- THAR Stock
- Financials Tharimmune, Inc.
